Eton Pharmaceuticals, Inc.
ETON
Revenue
9.07M
▲1.11M▲13.91%
3 Months ChangeAssets
31.82M
▲1.03M▲3.34%
3 Months ChangeLiabilities
18.36M
▲3.06M▲20.01%
3 Months ChangeFree Cash Flow
-2.49M
▼-939.00k▼-60.66%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-03
Form 8-K
ID: 0001437749-24-030557
2024-08-08
Form 10-Q
ID: 0001437749-24-025574
2024-08-08
Form 8-K
ID: 0001437749-24-025569
2024-07-15
Form 8-K
ID: 0001437749-24-022736
2024-06-21
Form 8-K
ID: 0001437749-24-020967
2024-06-11
Form 8-K
ID: 0001437749-24-019953
2024-05-09
Form 10-Q
ID: 0001437749-24-015697
2024-05-09
Form 8-K
ID: 0001437749-24-015686
2024-04-30
Form 8-K
ID: 0001437749-24-013838
2024-04-18
Form 8-K
ID: 0001437749-24-012443